Pharma Equity Group A/S (OCSE:PEG) Long-Term Capital Lease Obligation : kr0.18 Mil (As of Mar. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Pharma Equity Group A/S Long-Term Capital Lease Obligation?

Pharma Equity Group A/S's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr0.18 Mil.

Pharma Equity Group A/S's quarterly Long-Term Capital Lease Obligation increased from Sep. 2023 (kr0.05 Mil) to Dec. 2023 (kr0.23 Mil) but then declined from Dec. 2023 (kr0.23 Mil) to Mar. 2024 (kr0.18 Mil).

Pharma Equity Group A/S's annual Long-Term Capital Lease Obligation stayed the same from Dec. 2021 (kr0.00 Mil) to Dec. 2022 (kr0.00 Mil) but then increased from Dec. 2022 (kr0.00 Mil) to Dec. 2023 (kr0.23 Mil).

Pharma Equity Group A/S Long-Term Capital Lease Obligation Historical Data

The historical data trend for Pharma Equity Group A/S's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Equity Group A/S Long-Term Capital Lease Obligation Chart

Pharma Equity Group A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.23

Pharma Equity Group A/S Quarterly Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.22	0.12	0.05	0.23	0.18

Pharma Equity Group A/S (OCSE:PEG) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Pharma Equity Group A/S Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Pharma Equity Group A/S's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Equity Group A/S (OCSE:PEG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Equity Group A/S (OCSE:PEG) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Slotsmarken 18, 2.th., Horsholm, DNK, DK-2970

Website

https://www.pharmaequitygroup.com

Pharma Equity Group A/S is an investment company specializing in the life science industry. The group is focused on an early investment in various life science companies that develops technologies and therapies that have the potential to improve human health and quality of life. The group specializes in early-stage investments in biotechnology, that are developing novel therapies for unmet medical needs. Its portfolio consists of companies dedicated to developing novel, effective treatments for diseases with patient and social impact for which current therapy is lacking or in need of improvement.